Hvad er oversættelsen af " PLASMACLEARANCE " på engelsk?

• plasma clearance

Eksempler på brug af Plasmaclearance på Dansk og deres oversættelser til Engelsk

Elimination Total plasmaclearance lå i intervallet 2, 25- 2, 74 ml/ min/ kg.
Elimination Total clearance in plasma ranged 2.25- 2.74 ml/ minute/ kg.

Ved svært nedsat nyrefunktion(kreatininclearance< 30 ml/ min) er plasmaclearance ca.
In severe renal impairment(creatinine clearance< 30 ml/ min), plasma.

Plasmaclearance af montelukast er i gennemsnit 45 ml/ min hos raske voksne.
The plasma clearance of montelukast averages 45 ml/ min in healthy adults.

Den afsluttende halveringstid er 129±87 min., og plasmaclearance er 119±49 ml/ min.
The terminal half-life is 129± 87 min, and plasma clearance is 119± 49 ml/ min.

Plasmaclearance, fordelingsvolumen og halveringstid er uafhængige af dosis.
Plasma clearance, volume of distribution and half-life are independent of dose.

Hos ældre patienter samt patienter med nedsat nyrefunktion er gabapentins plasmaclearance nedsat.
In elderly patients, and in patients with impaired renal function, gabapentin plasma clearance is reduced.

Legemsvægt- Plasmaclearance af fondaparinux stiger i takt med legemsvægten 9% for hver 10 kg.
Body weight- Plasma clearance of fondaparinux increases with body weight 9% increase per 10 kg.

Distribution er, frem for ekskretion og biotransformation, den dominerende mekanisme der påvirker plasmaclearance.
Distribution, rather than excretion or biotransformation, is the dominant mechanism influencing plasma clearance.

Hos patienter med moderat nedsat nyrefunktion faldt topotecan plasmaclearance til 34% af værdien for kontrolgruppens patienter.
In patients with moderate renal impairment topotecan plasma clearance was reduced to 34% of the value in control patients.

Plasmaclearance og renalclearance af pregabalin er direkte proportionalt med kreatininclearance se pkt.
Pregabalin plasma clearance and renal clearance are directly proportional to creatinine clearance see section 5.2 Renal impairment.

Middel(± SD) distributionsvolumenet(Vz) var 316(± 752) ml/ kg, og middel(± SD) plasmaclearance(CL) var 7, 9(± 14, 7) ml/ min/ kg.
The mean(± SD) volume of distribution(Vz) was 316(± 752) ml/ kg and the mean(± SD) plasma clearance(CL) was 7.9(± 14.7) ml/ min/ kg.

Olanzapins plasmaclearance er lavere hos: ældre end hos yngre personer, kvinder end hos mænd og ikke- rygere end hos rygere.
The plasma clearance of olanzapine is lower in elderly versus young subjects, in females versus males, and in non-smokers versus smokers.

Hos patienter over 75 år, der gennemgik ortopædisk operation, blev plasmaclearance vurderet til 1, 2 til 1, 4 gange lavere end hos patienter under 65 år.
In patients> 75 years undergoing orthopaedic surgery, the estimated plasma clearance was 1.2 to 1.4 times lower than in patients< 65 years.

Olanzapins plasmaclearance er lavere hos ældre versus yngre forsøgspersoner, kvinder versus mænd og ikkerygere versus rygere.
The plasma clearance of olanzapine is lower in elderly versus young subjects, in females versus males, and in non-smokers versus smokers.

Der forekommer delvis mætning af first- pass- virkningen og reduceret plasmaclearance, når kropsbelastningen stiger med højere enkeltdoser eller flere doser.
Partial saturation of the first-pass effect and reduced plasma clearance occur as the body burden increases with higher single doses or on multiple dosing.

Plasmaclearance for AsIII var ikke ændret hos patienter med let nedsat nyrefunktion(kreatininclearance 50- 80 ml/ min) eller moderat nedsat nyrefunktion kreatininclearance 30- 49 ml/ min.
Plasma clearance of AsIII was not altered in patients with mild renal impairment(creatinine clearance of 50-80 mL/ min) or moderate renal impairment creatinine clearance of 30-49 mL/ min.

Hos patienter over 75 år, der gennemgik ortopædkirurgi og fik 2, 5 mg fondaparinux en gang daglig, blev plasmaclearance vurderet til 1, 2 til 1, 4 gange lavere end hos.
In patients> 75 years undergoing orthopaedic surgery and receiving fondaparinux 2.5 mg once daily, the estimated plasma clearance was 1.2 to 1.4 times lower.

Elimination Total plasmaclearance af rosiglitazon er omkring 3 l/ time, og den endelige halveringstid er cirka 3- 4 timer.
Elimination Total plasma clearance of rosiglitazone is around 3 l/ h and the terminal elimination half-life of rosiglitazone is approximately 3-4 h.

Hos patienter over 75 år, der gennemgik ortopædkirurgi og fik 2, 5 mg fondaparinux en gang daglig, blev plasmaclearance vurderet til 1, 2 til 1, 4 gange lavere end hos patienter under 65 år.
In patients> 75 years undergoing orthopaedic surgery and receiving fondaparinux 2.5 mg once daily, the estimated plasma clearance was 1.2 to 1.4 times lower than in patients< 65 years.

CHMP fandt det acceptabelt at fjerne denne kontraindikation, da den primære eliminationsvej for valsartan er biliær, og nyreclearance tegner sig for mindre end 30% af plasmaclearance.
The CHMP considered it acceptable to remove this contraindication, as the primary route of elimination of valsartan is via biliary route and renal clearance accounts for less than 30% of plasma clearance.

Plasmaclearance for AsIII hos patienter med alvorligt nedsat nyrefunktion(kreatininclearance mindre end 30 ml/ min) var 40% lavere sammenlignet med patienter med normal nyrefunktion se afsnit 4. 4.
The plasma clearance of AsIII in patients with severe renal impairment(creatinine clearance less than 30 mL/ min) was 40% lower when compared with patients with normal renal function see section 4.4.

Nedsat nyrefunktion Som forventet for et stof med en nyre- clearance på kun 30% af total plasmaclearance, er der ikke observeret nogen korrelation mellem nyrefunktion og systemisk eksponering af valsartan.
Impaired renal function As expected for a compound where renal clearance accounts for only 30% of total plasma clearance, no correlation was seen between renal function and systemic exposure to valsartan.

Gennemsnitlig plasmaclearance(CL) var 21, 9 ml/ t/ kg og gennemsnitlig distributionsvolumen ved steady state(Vss) var 66, 2 ml/ kg for begge dosisgrupper med lille variation mellem patienterne på henholdsvis 15% og 11.
Mean plasma clearance(CL) was 21.9 mL/ hr/ kg and mean volume of distribution at steady state(Vss) was 66.2 mL/ kg for both dose groups with small between-subject variability of 15% and 11%, respectively.

Hvordan man bruger "plasmaclearance" i en Dansk sætning

Denne virkning var ledsaget af en 24 % stigning i erlotinibs tilsyneladende plasmaclearance.

Fluticasonpropionats fordeling er karakteriseret ved en høj plasmaclearance (1.150 ml/min), et stort fordelingsvolumen ved steady state (ca.300 l) og en terminal halveringstid på ca. 8 timer.

Middeltallet for plasmaclearance efter intravenøs administration hos forsøgspersoner med cancer var > 200 l/time med moderate interindividuelle variationer (variationskoefficient [CV] ca. 50 %).

Quetiapins gennemsnitlige plasmaclearance blev reduceret med ca. 25 % hos individer grad i leveren forventes højere plasmaværdier hos individer med nedsat leverfunktion.

I et studie var plasmaclearance 12,7 ml/min hos personer med epilepsi, mens det hos raske forsøgspersoner er 5-10 ml/min.

Acceleration af plasmaclearance af terbinafin observeres under påvirkning af stoffer - induktorer af stofskifte, hæmning - under virkningen af ​​inhibitorer af cytokrom P450.

Quetiapins gennemsnitlige plasmaclearance var reduceret med 30 % til 50 % hos ældre, sammenlignet med yngre patienter.

Hvordan man bruger "plasma clearance" i en Engelsk sætning

Plasma clearance of neostigmine and pyridostigmine in the dog.

Renal plasma clearance of this substance can be the GFR.

Measurement of glomerular filtration rate with technetium-99mDTPA: Comparison of plasma clearance techniques.

The average plasma clearance for alvimopan was 402 (±89) mL/min.

Plasma clearance ranged between 110-116 ml/min.

Assessment of iothalamate plasma clearance : Duration of study affects quality of GFR.

Measurement of glomerular filtration rate: Single injection plasma clearance method without urine collection.

Assessment of glomerular filtration rate in diabetic nephropathy using the plasma clearance of 51Cr-EDTA.

Plasma clearance of ranitidine appears to be decreased in patients with renal dysfunction.

Total plasma clearance of active substance is approximately 8 ml/min. – Bekhterev’s disease (ankylosing spondylitis).